These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Treatment
1648 results:

  • 1. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM
    Methods Mol Biol; 2025; 2865():189-219. PubMed ID: 39424725
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Synthesis, Anti-Cancer Activity, Cell Cycle Arrest, Apoptosis Induction, and Docking Study of Fused Benzo[
    Khoder ZM; Mohamed MS; Awad SM; Gharib AF; Aly O; Khodair MAE; Fatahala SS; El-Hameed RHA
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407625
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Report of six cases with mast cell leukemia and a literature review].
    Zhu F; Yu Y; Chen CY; Duan WB; Jiang Q; Yan R; Sun Y; Han YQ; Zhang J; Wang H; Zhang QR; Chen SN; Yan WH; Cai MJ; Zhang ZB; Yin J; Wang Q
    Zhonghua Nei Ke Za Zhi; 2024 Oct; 63(10):996-1000. PubMed ID: 39375119
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SRPK Inhibitors Reduce the Phosphorylation and Translocation of SR Protein Splicing Factors, thereby Correcting
    Changphasuk P; Inpad C; Horpaopan S; Khunchai S; Phimsen S; Surangkul D; Janvilisri T; Silsirivanit A; Kaewkong W
    Front Biosci (Schol Ed); 2024 Sep; 16(3):17. PubMed ID: 39344395
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia.
    Lu Y; Jiang X; Li Y; Li F; Zhao M; Lin Y; Jin L; Zhuang H; Li S; Ye P; Pei R; Jin J; Jiang L
    J Transl Med; 2024 Sep; 22(1):867. PubMed ID: 39334157
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulator.
    Zhang L; Zhou X; Aryal S; Veasey V; Zhang P; Li FJ; Luan Y; Bhatia R; Zhou Y; Lu R
    Cell Death Dis; 2024 Aug; 15(8):627. PubMed ID: 39191721
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clitocine enhances the drug sensitivity of colon cancer cells by promoting FBXW7-mediated mcl-1 degradation via inhibiting the A2B/cAMP/ERK axis.
    Ruan F; Ruan Y; Gu H; Sun J; Chen Q
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C884-C900. PubMed ID: 39140602
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States.
    Peloquin S; Cymbalista F; Dreyling M; Shah NN; Murray S; Del Fiacco R; Muehlenbein CE; Lazure P
    BMC Cancer; 2024 Aug; 24(1):1003. PubMed ID: 39138575
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Altered neutrophil responses to dengue virus serotype three: delayed apoptosis is regulated by stabilisation of mcl-1.
    Kamsom C; Edwards SW; Thaosing J; Papalee S; Pientong C; Kurosu T; Phanthanawiboon S
    Sci Rep; 2024 Aug; 14(1):18414. PubMed ID: 39117747
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proteasome inhibition induces apoptosis through simultaneous inactivation of mcl-1/BCL-XL by NOXA independent of CHOP and JNK pathways.
    Chen W; Sun M; Sun Y; Yang Q; Gao H; Li L; Fu R; Dong N
    Toxicology; 2024 Nov; 508():153906. PubMed ID: 39117261
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Discovery of a Myeloid Cell leukemia 1 (mcl-1) Inhibitor That Demonstrates Potent
    Tarr JC; Salovich JM; Aichinger M; Jeon K; Veerasamy N; Sensintaffar JL; Arnhof H; Samwer M; Christov PP; Kim K; Wunberg T; Schweifer N; Trapani F; Arnold A; Martin F; Zhao B; Miriyala N; Sgubin D; Fogarty S; Moore WJ; Stott GM; Olejniczak ET; Engelhardt H; Rudolph D; Lee T; McConnell DB; Fesik SW
    J Med Chem; 2024 Aug; 67(16):14370-14393. PubMed ID: 39102508
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Initial AXL and mcl-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells.
    Matsui Y; Yamada T; Katayama Y; Hirai S; Sawada R; Tachibana Y; Ishida M; Kawachi H; Nakamura R; Nishioka N; Morimoto K; Iwasaku M; Horinaka M; Sakai T; Tokuda S; Takayama K
    Cancer Sci; 2024 Oct; 115(10):3333-3345. PubMed ID: 39039802
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS).
    Choquet S; Marchal C; Deygas F; Deslandes M; Macher N; de Pouvourville G; Levy V
    Ann Hematol; 2024 Aug; 103(8):2969-2981. PubMed ID: 38965145
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-leukemia Effects with Venetoclax.
    Hao W; Wang L; Xu T; Jia G; Jiang Y; Qin C; Li X
    Mar Drugs; 2024 May; 22(6):. PubMed ID: 38921561
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo.
    Ikhlef L; Ratti N; Durand S; Formento R; Daverat H; Boutaud M; Guillou C; Dmytruk N; Gachard N; Cosette P; Jauberteau MO; Gallet PF
    Cancer Gene Ther; 2024 Aug; 31(8):1164-1176. PubMed ID: 38918490
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Desmethylclomipramine triggers mitochondrial damage and death in TGF-β-induced mesenchymal type of A549 cells.
    Shih FC; Lin CF; Wu YC; Hsu CC; Chen BC; Chang YC; Lin YS; Satria RD; Lin PY; Chen CL
    Life Sci; 2024 Aug; 351():122817. PubMed ID: 38871113
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combining Mefloquine with an mcl-1 Inhibitor as a Novel Therapeutic Strategy for the treatment of Nasopharyngeal Carcinoma.
    Dong J; Zhang J; Xiang G; Yang L
    Nutr Cancer; 2024; 76(8):736-744. PubMed ID: 38795070
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis.
    Wang M; Robak T; Maddocks KJ; Phillips T; Smith SD; Gallinson D; Calvo R; Wun CC; Munugalavadla V; Jurczak W
    Blood Adv; 2024 Sep; 8(17):4539-4548. PubMed ID: 38781315
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Patient perspectives on treatment for mantle cell lymphoma and chronic lymphocytic leukemia in Japan.
    Kiguchi T; Hiramatsu Y; Ota S; Uchiyama M; Matsuo M; Okamura M; Morimoto S; Tanizawa Y; Tajimi M; Payakachat N
    J Clin Exp Hematop; 2024 Jun; 64(2):119-128. PubMed ID: 38749721
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TurboID-Based IRE1 Interactome Reveals Participants of the Endoplasmic Reticulum-Associated Protein Degradation Machinery in the Human Mast Cell leukemia Cell Line HMC-1.2.
    Ahmed N; Preisinger C; Wilhelm T; Huber M
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727283
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 83.